New hope for patients with cancer-induced bone diseases

Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.

David Ahern

David Ahern - Research Associate

Tal Arnon

PhD Tal Arnon - Professor of Cellular Immunology

Jennifer Cole

Jennifer Cole - Research Associate

Yuqing Long

Yuqing Long - Postdoctoral Research Associate in Mucosal Immunology

Haoliang Xue

Haoliang Xue - Senior Postdoctoral Research Associate in Bioinformatics and Spatial Transcriptomics

Daniel Petrossian

Daniel Petrossian - Research Assistant

Nicholas Ilott

Nicholas Ilott - Senior researcher and lead bioinformatician for the Oxford Centre for Microbiome Studies

Mark Coles

PhD, FRSB Mark Coles - Professor of Immunology and Lead for Industrial Strategy and Entrepreneurship

Michael Dustin

Michael Dustin - Kennedy Trust Professor of Molecular Immunology

Malvika Gulati

Malvika Gulati - DPhil student

Kim Midwood

BSc (Hons), PhD Kim Midwood - Kennedy Director of Graduate Studies

Sam Burnell

Sam Burnell - Graduate Studies Manager

Charlotte Turner

Charlotte Turner - Graduate Studies Officer

Yuchen Jiang

Yuchen Jiang - MSc Student (Part II Biochemistry)

Mohammadali Yavari Ramsheh

Mohammadali Yavari Ramsheh - Postdoctoral Research Associate in Bioinformatics

Neyan Georgeson Campo

Neyan Georgeson Campo - Kennedy Receptionist

Holly Campbell

Holly Campbell - Graduate Studies Assistant

Aleksandra Boikova

Aleksandra Boikova - Novo Nordisk Postdoctoral Research Fellow

Linyi Zhu

Ph.D. Linyi Zhu - Senior Research Fellow

Floriane Hendrickx

Floriane Hendrickx - MSc Student (Part II Biochemistry)

Search results

Found 9886 matches for